SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?


To: TigerPaw who wrote (208410)12/10/2001 12:16:13 PM
From: PROLIFE  Respond to of 769670
 
How does RU 486 work?

RU 486 kills a developing baby after his or her heart has begun to beat. It blocks a vital nutrient hormone, Progesterone. The embryonic baby, who had implanted into the nutrient lining of the mother’s womb at least two weeks earlier, can be compared to a grape on a vine. If the stem is pinched, preventing the nourishing sap from reaching the grape, it will wither, die and drop off. Just so, if this drug is used, it causes the embryonic baby to wither and die. A second drug, prostaglandin, is used to expel the dead baby from her womb.

Counting from the first day of her last normal menstrual period, it is effective only from the fifth through the seventh week. Some claim success, but with decreasing effectiveness, into the 9th week.

RU 486 alone is effective from 60 to 80% of the time. If Prostaglandin is added, the abortion rate rises to 95%. Couzinet et al., "Termination of Early Pregnancy by RU-486 (Mifepristone), New Eng. J. of Med., vol. 315, no. 25, Dec. 18, 1986 O. Ylikorkala et al., Outpatient Abortion With RU-486, OB-GYN, vol 74, no. 4, Oct. 1989 M. Rodger et al., Blood Loss . . . After RU-486 and Prostaglandin...," Contraception, vol. 40, no. 4, Oct. 1989. Science Magazine, Sept. 1989

How is it used?

First Visit: She must have a thorough history, physical exam and blood count. If she’s anemic, has high blood pressure, kidney disease, asthma, has a vaginal infection, smokes or is over 35, she is rejected. Finally, she needs an ultrasound exam to confirm the age of her baby and to rule out a tubal pregnancy. She must sign permission and, in some states or nations, wait 1 or more days. Second Visit: She takes the pills.

Third Visit: She is given the prostaglandin drug. This produces hard labor. Usually the baby parts are passed that day.

Fourth Visit: If she has not aborted or if there is still bleeding, she will need an ultrasound to determine if the uterus is empty. If not, she needs a D&C. The

French Ministry of Health requires that the abortion facility be equipped with an EKG, IV equipment, and a "crash cart" with a defibrillator in the event of a heart attack resulting from the drugs.

There are complications?

Yes. Bleeding is the most common. In the controlled testing reported, one woman in a hundred bled so badly she either needed a D&C (surgical scraping out of her womb) and/or a blood transfusion. In an underdeveloped country, such a treatment would normally not be available and, very likely, some of these women would bleed to death. e.g., In a controlled trial in the state of Iowa, one woman took the pills and went home. She bled so badly She needed four emergency blood transfusions to save her life. Interruption of Preg. with RU-486 & Prostaglandin, Silvestre et al., N. Eng. J. Med., Vol. 322, 3/8/90, No. 10 Efficacy of Mifepristone & Prostaglandin in 1st Trimester Abortion, UK Multicentre Trial, Br. J. OB/Gyn, June ’90, Vol. 97, pp. 480-486

Other complications include substantial pain, tubal pregnancies, incomplete abortion, uterine rupture, e.g., an 18-week abortion with RU 486 and prostaglandin produced rupture of the uterus and a near fatality. Uterine Rupt.-Ab.-Second Trimester: J. Norman, Br. J. Ob/Gyn, vol. 102, Apr. ’95, p. 332

Psychological upset ranging from mild to serious, post-abortion syndrome and, in a few cases, death of the woman occur.

Are there problems with the baby?

RU 486 and a prostaglandin will produce an abortion 95% of the time. The rest will be advised to have a surgical abortion. But there will be some who will refuse surgery and carry to term. These babies will have a significant possibility of fetal deformity. Why?

Two poisonous drugs were given when the heart, limbs, etc., were being formed. This didn’t quite kill, but the effect can be to cause severe structural deformities as a direct toxic effect, similar to those from Thalidomide. This drug may have an action similar to DES, which was used in the ’60s to prevent miscarriage, and which turned out to be a chemical time bomb. RU 486 also can, in the body, react chemically to produce free radicals, which can combine with DNA, the genetic building blocks of our bodies. Through this mechanism fetal deformity can be produced at birth, and/or possibly show up 20 or more years later as a malformation or even cancer, such as the DES did. It is even possible that it could unite with maternal DNA to produce cancer or fetal defects in subsequent offspring. In addition, the drugs can cause genetic damage to the developing baby and, if to the mother, damage to children she bears later, similar to the DES drug tragedy.

In the tightly controlled French experience, there has been one such tragedy. Under the far looser private care in North America, the number of deformed babies should be greater.

Two French researchers report on two women who continued their pregnancies after their RU 486 failed to cause abortion. One delivered a normal baby. "The second pregnancy was terminated because of malformations (sirenomelia)" [fusion of lower extremities] J.C. Pons et al., letter to Lancet, Scrip, Sept. 26, 1991

Aren’t there therapeutic uses?

To date, there are no proven uses of RU 486 to treat any human illness. Research is underway testing whether it will have any beneficial effect on one type of breast cancer, on meningioma (brain tumor), Cushing’s Syndrome or endometriosis. No serious research is projected for any other conditions. Note that pro-life groups have never opposed research with RU 486 to find therapeutic uses. To date all studies of this drug were paid for by or associated with the manufacturer.

Where can I find more details?

A pamphlet, "RU 486, A Human Pesticide," is available from Hayes Publishing Company in Cincinnati Phone (513) 681-7559.



To: TigerPaw who wrote (208410)12/10/2001 12:21:40 PM
From: PROLIFE  Respond to of 769670
 
RU-486:
THE REST OF THE STORY
by Dr. Eugene Diamond
RU-486 is one of a new class of drugs whose function is to block end organ receptors of various hormones. When end organ receptors are blocked, the effect of a hormone and various hormone dependent processes are interrupted or altered. RU-486 blocks various end organ receptors but its principal clinically relevant action is to block progesterone receptors.
Since progesterone is necessary for the maintenance of pregnancy, blocking its effect will result in the termination of the pregnancy. Progesterone is necessary to maintain the endometrium which provides a nourishing bed for the implantation and development of the fetus. With RU-486, progesterone is blocked and the endometrium no longer is able to nourish the developing child, which starves and is sloughed out.

It has taken a while for the manufacturers and researchers dealing with clinical applications of RU-486 to decide on its true mode of action.

RU-486 was first promoted as a "morning after pill" to be used after unprotected intercourse. It was discovered, however, that it was not effective early in pregnancy before progesterone levels had reached a critical threshold.

It was then promoted as a "menstrual regulator" -- i.e. a pill a woman could take every month and not even know if she were aborting, thereby, presumably, relieving her conscience. It was discovered, however, that RU-486 causes the phenomenon of "dyssynchrony" in which a woman's ovulatory and menstrual cycles become unlinked -- reducing the drug's effectiveness in terminating any pregnancy.

In 1987, Dr. Beaulieu, the discoverer of RU-486, boasted that RU-486 would completely replace surgical abortions in the first 10 weeks of pregnancy, which is when 80 percent of surgical abortions take place. As a matter of fact, the drug does not work very well after the seventh week of pregnancy and is really only safe and effective when taken during a three week window of opportunity from the fourth to the seventh week. In addition, the drug is not recommended for women over age 35.

When given to induce abortion during the first weeks, RU-486 works about 60 percent of the time. When combined with prostaglandin it is effective about 80 percent of the time. A second course of prostaglandin will abort an additional 15 percent and the remaining 5 percent will require a surgical abortion.

Six or Seven Visits
According to an International Inquiry Commission on RU-486 convened in Paris,1 the proper use of RU-486 involves not a simple home administration of pills but actually a potential six or seven visits to the physician or clinic in order to:
1. Confirm the pregnancy and take RU-486 under supervision.

2. Spend 12 hours in the hospital for prostaglandin injections.

3. Expel the fetus, with resultant hemorrhage and discomfort in 80 percent of cases.

4. Obtain repeat prostaglandin injections in 20 percent of patients.

5. Obtain surgical abortion on those in whom both drugs are ineffective.

6. Undergo ultrasound examination several days later to make sure all parts of the unborn child have been expelled.

In 5 to 10 percent of cases another admission to the hospital will be necessary to control and treat excessive hemorrhage.

Bleeding occurs in over 90 percent of women taking RU-486. Excessive hemorrhage may lead to the need for transfusion and/or D&C.

The next issue beyond ease of administration and simplicity of use is the question of safety. Putting aside the routine side effects of nausea, vomiting and uterine cramps and inevitable hemorrhage (which can be trivialized or maximized depending on one's ideological viewpoint) the real issue of safety centers on the necessity for employment of prostaglandins.

Nobody believes that the use of prostaglandins is safe and innocuous. These are highly active biological compounds which have marked cardiovascular actions requiring close supervision. There is a statement prepared by a joint committee of the French Republic signed by the Director of General Health, the Director of Hospitals and the Director of Pharmacy and Medicine2.

RU-486, CPR and ICU
This directive requests that whenever prostaglandins are given, cardiopulmonary resuscitation equipment and electrocardiographic machines be at standby, a defibrillator be available, calcium channel blockers drawn up in a syringe, and vital signs be monitored over a period of several hours.
What this says, in effect, is that prostaglandins be given only in what amounts to an Intensive Care Unit. This communication, which was sent to all physicians and hospitals in France, followed a fatal cardiac reaction to prostaglandins in a woman who had received the drug after RU-486. It is difficult to sustain the notion of safety against the background of such warnings.

In contrast, an article in the New England Journal of Medicine3 concluded RU-486 "is effective and safe." All six authors of this paper are employees of the company which manufactures the drug and will profit from it.

Very little consideration is given, of course, to the safety of the drugs for the unborn child who is intended to be killed. It must be a matter of concern, however, in those instances where the woman changes her mind after taking the drug and where the drug is only partially effective.

Thalidomide-type Deformities
In those cases where the endometrium is partially disrupted, deformities due to impaired nutrition may occur. Also, the drug itself is similar in chemical structure to other teratogens and might be expected to produce deformities. There have been sporadic reports of such abnormalities, mostly limb-bud anomalies similar to those caused by Thalidomide.4
This raises the issue of who will be the experimental animals while this drug is being tested for safety over time. As we know now, the first generation of contraceptives was unsafe due to their estrogen content. The estrogen component was responsible for an unacceptable rate of thromboembolic complications, including stroke, pulmonary embolus and myocardial infarction. This resulted in a response by manufacturers and a dramatic reduction of the estrogen content to the level of mini pills or its elimination entirely in the progestin-only pills.

American women were the guinea pigs during this trial and error period of field testing, just as they were during the scandalous and immoral coverup of the side effects of the Dalkon Shield and other unsafe intrauterine devices.

It is now proposed that RU-486 be made available for the same type of high-risk experimentation. Professor Pierre de Vernejoul, Chairman of the International Inquiry Commission on RU-486 has stated: "The medical and scientific approach has been sacrificed to ideological motives."

In the promotion of RU-486, a clever but unscrupulous technique has been used to discredit opposition. This has been to create a phony confrontation between the "men of science" and the "know nothings." It is alleged in this kind of propaganda that the many scientific uses of RU-486 are being sacrificed to political motives and that science is being stifled or held hostage by some sort of straw man right-to-lifer more interested in fetuses than adult human beings.5

Dr. Beaulieu has been somewhat more honest than some of his radical feminist propagandists in this regard. In accepting his Lasker Award, he made no pretense of marketing the pill as anything other than an abortifacient -- or, as he said euphemistically, a "contragestive."6

It is important to remember that there is no embargo on the use of RU-486 for research in uses other than as abortifacients. The President of Rousell-Uclaf, the manufacturer, has stated that the company can and does make it available for use for other experimental indications.7 The U.S. federal government and the U.S. Food and Drug Administration have said likewise.

Curative Claims
Nevertheless, drumbeats of the alleged effectiveness of mifepristone (RU-486) are used to drown out the abortion arguments.

It has been alleged to be effective in the treatment of brain tumors.8 This is based on an article by Rogelson in which he noted the presence of progesterone receptors in some meningeomas. This observation has not been tested therapeutically.

RU-486 has been shown to block other hormones, particularly cortisol in Cushings Disease. It has been tried in one study by Bertagna9 who states that RU-486 should not be considered a routine alternative for the treatment of Cushings Disease. A similar report by Nieman came to the same conclusion -- i.e. effective but not proven safe.10

The allegation that it might be used in certain hormone dependent tumors, including those in the breast is, thus far, a speculation based on RU-486's mode of action unsupported by any conclusive research.11

Studies on hypertension12 and immunity13 are not only based on actual research but are derived from speculation which is far fetched and probably irrelevant.
All of these studies have been reviewed and evaluated by Dr. Joe McIlhaney of the University of Texas.14 It is important to remember that the F.D.A., since the Thalidomide disaster, has required that every new drug be subjected to progeny studies. That is, the proposed new drug must be shown by animal studies to be safe and effective not only for patient but also safe for her unborn child if she is pregnant.

If RU-486 were proposed as a treatment for Cushings Disease, for example, it could not pass these progeny studies, since it could not be shown to be safe for use by a pregnant woman with Cushings Disease.

Summary
RU-486 is capable of producing the death of a developing unborn child through blocking progesterone receptors and with consequent disruption of the nutrient bed of the endometrium. It is one of a class of drugs which may have other therapeutic uses by way of receptor blockage, but its only established use is for abortifacience.
The use of RU-486 with prostaglandins is a high-risk therapeutic method which would preclude its ever being used by women during pregnancy except under close and complex medical supervision. The current climate in the medical community is typical advocate science with an unwarranted trivialization of potential toxicity and exaggerated claims of scientific breakthrough.

Dr. Eugene F. Diamond is well known as a pediatrician and educator. He is professor of pediatrics, Loyola University Stritch School of Medicine; visiting professor, Rush Medical College; and acting chairman, Department of Pediatrics at Loyola University. He has served as president of the Illinois Academy of Pediatrics and is currently chairman of the Bioethics Section -- American Academy of Pediatrics.

This article originally appeared in the January 1993 issue of Family Resources Center News, Peoria, Illinois, USA. Reprinted with permission.

Bibliography
1 Dunham, S. International Inquiry Commission Condemns RU-486. Wanderer 125:9, 1992.
2 The French Republic. French Official Warn on Use of RU-486. Child & Family 21:102, 1992.

3 Silvestre, L. et. al. Voluntary Interruption of Pregnancy with RU-486. New England Journal of Medicine. 322-645, 1990.

4 Fonseca, W., et. al. Misoprostal Plus Mifepristone. Lancet 338:1594, 1991.

5 Rogelson, W., et. al. Beyond Abortion: RU-486. JAMA 264 1027, 1990.

6 Beaulieu, E. RU-486 As an Antiprogesterone Steroid. JAMA 262:1808, 1989.

7 Dr. Ariel Mouttet, Director of Marketing for Hormonal Drugs. Roussel-Uclaf Pharmaceutical, quoted by Susanne Fowler - Chicago Tribune in "Battle Lines."

8 Poisson, M., et. al. Journal of Neuroendocrinology 1:179, 1983.

9 Bertagna, O., et. al. Pituitary Adrenal Response to RU-486. Journal of Endocrinology and Metabolism 63:639, 1986.

10 Nieman, L.K. Treatment of Cushing's Syndrome with RU-486. Journal of Endocrinology & Metabolism 61:536, 1984.

11 Romieu, S. RU-486 in Advanced Breast Cancer. Cancer 74:455, 1987.

12 Kalimi. The Role of RU-486 in Dexamethasone Induced Hypertension in Rats. J.AM. Physical 256:682, 1989.

13 Rhim, J. Glucocortoids Enhance Viral Transformation of Mammalian Cell. Proceedings of Society for Experimental Biology in Medicine 174:217, 1983.

14 McIlhaney, J. RU-486, Wonder Drug? Insight, Family Research Council, No. 4, Dec. 1991.



To: TigerPaw who wrote (208410)12/10/2001 12:35:09 PM
From: Neocon  Read Replies (1) | Respond to of 769670
 
LOL! It is a much better definition to say that the woman couldn't be bothered using birth control because, if worse came to worse, she could get an abortion. Anyway, no one is prevented for getting a full array of contraception. Griswald, the Supreme Court decision upon which Roe was ostensibly based, ensured that contraception would be legal throughout the country. As for Ru486, maybe, who knows?